FilingFirehose · free AI preview
Kyverna Therapeutics, Inc.
KYTX · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Officer Departure
Kyverna Therapeutics filed a Form 8-K on May 18, 2026 disclosing an officer departure—a material event that warrants context. Our 90-day window captured one red flag; the full Report examines 12-month filing history, calculates dilution risk from equity raises, and maps financing trajectory against clinical milestones. The $49 Report adds dilution-risk scoring, complete 8-K event sequencing, and AI-detected anomalies in disclosure patterns that may signal capital structure risk.
Want the full 5-section $49 Report on KYTX?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.